Phase I study of Preoperative Chemo/Radiation (Concurrent Irinotecan/Cisplatin/RT) followed by surgery in limited stage small cell lung cancer (SCLC-LS)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Irinotecan
- Indications Small cell lung cancer
- Focus Adverse reactions
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2010 Actual end date added 1 Oct 2009 as reported by ClinicalTrials.gov.
- 12 Feb 2010 Biomarkers information updated